When the Eaton fire tore through Altadena, a collapsed garage revealed what looked like another total loss: a smoke-damaged ...
This Briggs & Stratton engine rebuild focuses on bringing long-term functionality back to a worn engine. By applying solid rebuilding principles and careful tuning, the project shows how classic ...
Warren CAT recently opened its new Engine Rebuild Center in Midland with a ribbon-cutting ceremony and grand opening celebration. (Courtesy Photo) MIDLAND Warren CAT, a locally owned and ...
MIDLAND, Texas — Warren CAT, an authorized Caterpillar dealer, is expanding its operations in the Permian Basin with a new $100 million Engine Rebuild Center designed to keep oil and gas machinery in ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The neurological disease drug ...
GM made some big changes to the Chevy Traverse, GMC Acadia, and Buick Enclave crossovers over the course of the last few model years, with all three recently making the move from the naturally ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Activist investor Engine Capital ...
Sept 24 (Reuters) - Activist investor Engine Capital has urged Acadia Healthcare (ACHC.O), opens new tab to add directors to its board and explore a potential asset sale to fund buybacks, sending the ...
Update 12:30pm: Updates shares, adds company comment. "We believe the Company’s undervaluation and sustained negative returns are due to ineffective execution, a bloated corporate structure, poor ...
Soleno Therapeutics is breathing easier with a report from Acadia Pharmaceuticals that its candidate to treat hyperphagia in patients with Prader-Willi Syndrome (PWS) has come up short in a phase 3 ...
Acadia Healthcare (NASDAQ:ACHC) rose 4% in premarket trading after activist Engine Capital reported a 3% stake in the behavioral healthcare operator and is pushing for board changes and other moves.
Sept 24 (Reuters) - Acadia Pharmaceuticals (ACAD.O), opens new tab said on Wednesday it will discontinue development of its intranasal therapy to treat a rare genetic condition after it failed to show ...